A presentation at AONN+ Annual Conference draws a connection between navigation and improved clinical trial accrual and NGS testing adherence.

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDsOxford, UK ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

An announcement from Natural Gas Services Group ( ($NGS) ) is now available. On November 10, 2025, Natural Gas Services Group announced its ...

TORONTO, Nov. 10, 2025 /CNW/ - Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion Detection Kit has received marketing authoriza ...

A few years ago, a new NGS platform being announced at the Advances in Genome Biology and Technology (AGBT) meeting would not have been a surprise; multiple new instruments entered the NGS arena over ...

Reports Q3 revenue $43.4M, consensus $43.25M. “NGS delivered another strong quarter, extending our momentum and reinforcing the durability of our ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today announces that it will be presenting brand-new data on ...

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...

Detailed price information for Natural Gas Services Group (NGS-N) from The Globe and Mail including charting and trades.